Cargando…

Impact of potential pregabalin or duloxetine drug–drug interactions on health care costs and utilization among Medicare members with fibromyalgia

PURPOSE: To examine the impact of newly initiated pregabalin or duloxetine treatment on fibromyalgia (FM) patients’ encounters with potential drug–drug interactions (DDIs), the health care cost and utilization consequences of those interactions, and the impact of treatment on opioid utilization. PAT...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ellis, Jeffrey J, Sadosky, Alesia B, Ten Eyck, Laura L, Cappelleri, Joseph C, Brown, Courtney R, Suehs, Brandon T, Parsons, Bruce
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204911/ https://www.ncbi.nlm.nih.gov/pubmed/25339847 http://dx.doi.org/10.2147/CEOR.S66759

Ejemplares similares

A retrospective, matched cohort study of potential drug-drug interaction prevalence and opioid utilization in a diabetic peripheral neuropathy population initiated on pregabalin or duloxetine
por: Ellis, Jeffrey J, et al.
Publicado: (2015)

Real-world comparison of health care utilization between duloxetine and pregabalin initiators with fibromyalgia
por: Peng, X, et al.
Publicado: (2014)

Patterns of health care utilization related to initiation of amitriptyline, duloxetine, gabapentin, or pregabalin in fibromyalgia
por: Kim, Seoyoung C, et al.
Publicado: (2015)

Impact of a Novel Cost-Saving Pharmacy Program on Pregabalin Use and Health Care Costs
por: Martin, Carolyn, et al.
Publicado: (2016)

Pain relief and functional improvement in patients with neuropathic pain associated with spinal cord injury: an exploratory analysis of pregabalin clinical trials
por: Sadosky, Alesia, et al.
Publicado: (2016)

A systematic review of the effectiveness of policies restricting access to pregabalin
por: Stacey, Brett R., et al.
Publicado: (2017)

Humanistic and economic burden of fibromyalgia in Japan
por: Lee, Lulu K, et al.
Publicado: (2016)

Characterizing classes of fibromyalgia within the continuum of central sensitization syndrome
por: Davis, Fred, et al.
Publicado: (2018)

Comparing common reasons for inpatient and outpatient visits between commercially-insured duloxetine or pregabalin initiators with fibromyalgia
por: Zhao, Yang, et al.
Publicado: (2012)

Identification of symptom and functional domains that fibromyalgia patients would like to see improved: a cluster analysis
por: Bennett, Robert M, et al.
Publicado: (2010)

Duloxetine for the management of fibromyalgia syndrome
por: Scholz, Beth A, et al.
Publicado: (2009)

Clinical utility, safety, and efficacy of pregabalin in the treatment of fibromyalgia
por: Bhusal, Santosh, et al.
Publicado: (2016)

Duloxetine and pregabalin in neuropathic pain of lung cancer patients
por: Gül, Şule Karabulut, et al.
Publicado: (2020)

Psychometric properties of a single-item scale to assess sleep quality among individuals with fibromyalgia
por: Cappelleri, Joseph C, et al.
Publicado: (2009)

Pregabalin in Treatment-Refractory Fibromyalgia
por: Stacey, Brett R, et al.
Publicado: (2010)

Pregabalin for the management of fibromyalgia syndrome
por: Boomershine, Chad S
Publicado: (2010)

Effectiveness of pregabalin for the treatment of chronic low back pain with accompanying lower limb pain (neuropathic component): a non-interventional study in Japan
por: Taguchi, Toshihiko, et al.
Publicado: (2015)

Effect of duloxetine in patients with fibromyalgia: tiredness subgroups
por: Bradley, Laurence A, et al.
Publicado: (2010)

Predictors of duloxetine adherence and persistence in patients with fibromyalgia
por: Cui, Zhanglin, et al.
Publicado: (2012)

Reliability of a 1-week recall period for the Medical Outcomes Study Sleep Scale (MOS-SS) in patients with fibromyalgia
por: Sadosky, Alesia, et al.
Publicado: (2009)

Toward characterization and definition of fibromyalgia severity
por: Silverman, Stuart, et al.
Publicado: (2010)

Effect of duloxetine on neuropathic pain in patients intolerant to continuous administration of pregabalin
por: Shimada, Yohei, et al.
Publicado: (2017)

Comparison of the Efficacy of Duloxetine and Pregabalin in Pain Relief Associated with Diabetic Neuropathy
por: Shahid, Wajeeha, et al.
Publicado: (2019)

Painful Diabetic Peripheral Neuropathy: Results of a Survey Characterizing the Perspectives and Misperceptions of Patients and Healthcare Practitioners
por: Sadosky, Alesia, et al.
Publicado: (2013)

New treatment options for fibromyalgia: critical appraisal of duloxetine
por: Üçeyler, Nurcan, et al.
Publicado: (2008)

Perspectives on the impact of painful diabetic peripheral neuropathy in a multicultural population
por: Eichholz, Martin, et al.
Publicado: (2017)

Health care utilization and expenditures among Medicaid beneficiaries with neuropathic pain following spinal cord injury
por: Margolis, Jay M, et al.
Publicado: (2014)

Duloxetine in the treatment of chronic pain due to fibromyalgia and diabetic neuropathy
por: Wright, Alan, et al.
Publicado: (2010)

Typology of patients with fibromyalgia: cluster analysis of duloxetine study patients
por: Lipkovich, Ilya A, et al.
Publicado: (2014)

Duloxetine for fibromyalgia syndrome: a systematic review and meta-analysis
por: Migliorini, Filippo, et al.
Publicado: (2023)

Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain
por: Quilici, Sibilia, et al.
Publicado: (2009)

Evaluation of efficacy and safety of gabapentin, duloxetine, and pregabalin in patients with painful diabetic peripheral neuropathy
por: Devi, Padmini, et al.
Publicado: (2012)

Pregabalin, the lidocaine plaster and duloxetine in patients with refractory neuropathic pain: a systematic review
por: Plested, Melanie, et al.
Publicado: (2010)

Therapeutic effects of diclofenac, pregabalin, and duloxetine on disuse-induced chronic musculoskeletal pain in rats
por: Ohmichi, Yusuke, et al.
Publicado: (2018)

A Comprehensive Drug Safety Evaluation of Pregabalin in Peripheral Neuropathic Pain
por: Freynhagen, Rainer, et al.
Publicado: (2015)

Pregabalin for the Treatment of Drug and Alcohol Withdrawal Symptoms: A Comprehensive Review
por: Freynhagen, Rainer, et al.
Publicado: (2016)

A cross-sectional study examining the psychometric properties of the painDETECT measure in neuropathic pain
por: Cappelleri, Joseph C, et al.
Publicado: (2015)

Measurement properties of painDETECT by average pain severity
por: Cappelleri, Joseph C, et al.
Publicado: (2014)

Characterizing individual painDETECT symptoms by average pain severity
por: Sadosky, Alesia, et al.
Publicado: (2016)

Characterizing neuropathic pain profiles: enriching interpretation of painDETECT
por: Cappelleri, Joseph C, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_q9gknsr2aeee9ocl4apqj1brta